Her2-neu: a target in lung cancer?
- PMID: 14679110
- DOI: 10.1093/annonc/mdh033
Her2-neu: a target in lung cancer?
Comment on
-
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.Ann Oncol. 2004 Jan;15(1):19-27. doi: 10.1093/annonc/mdh031. Ann Oncol. 2004. PMID: 14679114 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
